FDA Authorizes First Wearable Device to Continuously Monitor Glucose, Ketones

◆ ◆ The Wire takeaway

Medtech founders focused on metabolic monitoring face a new FDA clearance pathway; the bar is set for integrated continuous sensing devices that combine glucose and ketones. You need to act fast to adapt product roadmaps or risk losing ground to this standard-setting wearable.